Exchange: NASDAQ·Updated 10:56 AM EDT

About

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates for solid and liquid tumors and gamma-delta T cell engagers for cancer and autoimmune diseases. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17

Frequently Asked Questions

What is Market Cap of IN8bio Inc?
What is the 52-week high for IN8bio Inc?
What is the 52-week low for IN8bio Inc?
What is IN8bio Inc stock price today?
What was IN8bio Inc stock price yesterday?
What is the PE ratio of IN8bio Inc?
What is the Price-to-Book ratio of IN8bio Inc?
What is the 50-day moving average of IN8bio Inc?
How many employees does IN8bio Inc have?

Advertisement|Remove ads.